@misc{Biernacka-Fijałkowska_Barbara_Contrast-induced_2010,
 author={Biernacka-Fijałkowska, Barbara},
 address={Kraków},
 howpublished={online},
 year={2010},
 school={Wydział Lekarski},
 language={pol},
 abstract={Contrast-induced nephropathy (CIN) is a serious complication after exposure to iodinated contrast media. Recent studies show that N-acetylcysteine may play a significant role in prevention of CIN. The aim of his study was to evaluate the incidence of contrast-induced nephropathy in patients undergoing angiography and/or angioplasty procedures, to asses the efficacy of intravenous N-acetylcysteine in prevention of this complication and to asses the long term adverse effects of contrast-induced nephropathy. Results: Contrast-induced nephropathy was observed in 18,4% patients undergoing angiography and/or angioplasty procedures. The incidence of CIN was significantly reduced in patients receiving intravenous N-acetylcysteine as compared to patients receiving hydration with normal saline alone. The search for independent risk factors of contrast-induced nephropathy was performed. This revealed the following predictors: diabetes mellitus and impaired renal function (with eGFR < 60 ml/min/1,72m²), heart failure and volume of contrast medium administered. The risk of CIN was reduced in patients administered isoosmolal contrast medium. Probability of survival free of the following adverse events : cardiovascular death, heart infarct, dialysis, rehospitalization due to cardiac or renal causes was reduced in patients with contrast-induced nephropathy. Conclusions: The rate of long-term a},
 abstract={dverse events was higher in patients with contrast-induced nephropathy. Administration of intravenous N-acetylcysteine reduces the risk of CIN.},
 title={Contrast-induced nephropathy in patients undergoing angiography and angioplasty procedures},
 type={Praca doktorska},
 keywords={iodinated contrast media, contrast-induced nephropathy, acute kidney injury, N-acetylcysteine},
}